Growth Metrics

Thermo Fisher Scientific (TMO) Total Current Liabilities (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Total Current Liabilities readings, the most recent being $14.6 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 10.98% to $14.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $14.6 billion, a 10.98% increase, with the full-year FY2025 number at $15.2 billion, up 13.93% from a year prior.
  • Total Current Liabilities hit $14.6 billion in Q1 2026 for Thermo Fisher Scientific, down from $15.2 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $17.0 billion in Q4 2022 to a low of $11.0 billion in Q3 2022.
  • Median Total Current Liabilities over the past 5 years was $14.1 billion (2023), compared with a mean of $13.9 billion.
  • Biggest five-year swings in Total Current Liabilities: surged 72.55% in 2022 and later decreased 17.62% in 2023.
  • Thermo Fisher Scientific's Total Current Liabilities stood at $17.0 billion in 2022, then fell by 17.62% to $14.0 billion in 2023, then decreased by 4.85% to $13.3 billion in 2024, then rose by 13.93% to $15.2 billion in 2025, then decreased by 3.74% to $14.6 billion in 2026.
  • The last three reported values for Total Current Liabilities were $14.6 billion (Q1 2026), $15.2 billion (Q4 2025), and $14.9 billion (Q3 2025) per Business Quant data.